Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06501118 · ClinicalTrials.gov registry record · NA
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
A NA study of Respiratory Failure and Hypoxia, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 3,600
- Enrollment target
- 1
- Study location
NCT06501118: Recruiting NA study of Respiratory Failure and Hypoxia, sponsored by University of Colorado, Denver.
NCT06501118 is a NA study of Respiratory Failure and Hypoxia that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 3,600 participants, below the 4,434-participant average among 40 other Respiratory Failure trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06501118, a NA study of Respiratory Failure and Hypoxia, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,600 participants
- Enrollment target
- 1
- Study location
Study Summary
A multimodal educational intervention to target an oxygen saturation target range (SpO2 90-96%) will reduce ventilator length of stay and reduce occult hypoxemia by increased awareness and adherence to a designated oxygen saturation target range.
Primary Outcome
The number of days the patient will be free of mechanical ventilation
Conditions Studied
Interventions
- OTHER Education
- BEHAVIORAL Epic notification alert
Study Locations (1)
Colorado
- University of Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,600 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What NCT06501118 shows while recruiting
NCT06501118 is an interventional study that assigns participants to a tested intervention. Its 3,600 participants enrollment target places it among the larger protocols in the corpus, below the 4,434-participant average among 40 other Respiratory Failure trials with a reported enrollment target (19% lower).
The record links to 6 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Education is the first listed.
NCT06501118 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06501118 about?
NCT06501118 is a clinical study titled "Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients". A multimodal educational intervention to target an oxygen saturation target range (SpO2 90-96%) will reduce ventilator length of stay and reduce occult hypoxemia by increased awareness and adherence to a designated oxygen saturation target range.
What is the current status of trial NCT06501118?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,600 participants. The study started on 2024-09-01. Estimated completion is 2026-07-31.
What conditions does trial NCT06501118 study?
This clinical trial studies the following conditions: Respiratory Failure, Hypoxia, Hypoxemia, Acute Hypoxemic Respiratory Failure, Acute Hypoxic Respiratory Failure.
What interventions are being tested in trial NCT06501118?
The interventions under investigation include: Education (OTHER), Epic notification alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT06501118?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06501118 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06501118's enrollment target sits among peer trials
3,600 4th of 40 higher than 37 of 40 other Respiratory Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Analgesia-First Sedation in Trauma Patients
RECRUITING · NA
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Supraglottic Airway for Resuscitation in Preemies
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06088498 · 3,600 participants · Phase 2
App for Reducing Cravings to Smoke
- NCT06919419 · 3,600 participants · NA
HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
- NCT07091032 · 3,600 participants · NA
Building Connections
- NCT03199651 · 3,584 participants · NA
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI